While animal models, including the imiquimod-induced dermatitis model for psoriasis, effectively replicate essential pathological characteristics, notably the Th17-mediated inflammation driven by IL-17 and IL-23, other conditions, such as AD, are influenced by a complex interaction of immune pathways, primarily Th2 and Th22, in conjunction with Th17. This evidence concerns the gene IL17A and skin disorder.